Laderma - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 11,593 | 15,274 | 14,733 | 10,405 | 15,269 | 15,946 | 15,744 | 10,288 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | -14,398 | -9,974 | -2,061 | -5,718 | -4,386 | -4,117 | -5,756 | -4,681 |
| Equity | -49,092 | -59,066 | -61,127 | -6,641 | -11,027 | -15,144 | -20,900 | -25,581 |
| Liabilities | 59,660 | 61,399 | 71,884 | 29,052 | 29,246 | 29,783 | 31,064 | 35,395 |
| Non-current assets | 8,377 | 1,675 | 16,959 | 13,260 | 9,560 | 5,860 | 2,160 | 2 |
| Current assets | 2,182 | 626 | 9,302 | 8,778 | 8,280 | 8,445 | 7,710 | 9,621 |
| Total assets | 10,559 | 2,301 | 26,261 | 22,038 | 17,840 | 14,305 | 9,870 | 9,623 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 2,974 | 1,734 | 657 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +175.6% | +31.8% | -3.5% | -29.4% | +46.7% | +4.4% | -1.3% | -34.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -136.4% | -433.5% | -7.8% | -25.9% | -24.6% | -28.8% | -58.3% | -48.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -124.2% | -65.3% | -14.0% | -55.0% | -28.7% | -25.8% | -36.6% | -45.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 11,593 | 15,274 | 14,733 | 10,405 | 15,269 | 15,946 | 15,744 | 10,288 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Laderma - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-09-18 | 2023-09-18 | 53.75 |
Laderma - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2024-12-30 | 2025-01-27 | 0.01 |
| 2024-12-03 | 2024-12-27 | 0.01 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Laderma, UAB, company code 303490861, is a Private Limited Liability Company operating in other human health activities n.e.c. In 2025, the latest financial year, revenue decreased to €10.3K from €15.7K in 2024, a year-on-year decline of 34.6%. Net loss remained negative at €4.7K, and the profit margin widened to -45.5%, indicating weaker profitability than in previous years. The 2023–2025 trajectory shows a steady fall in turnover from €15.9K to €10.3K, while losses persisted each year: €4.1K in 2023, €5.8K in 2024 and €4.7K in 2025. Balance sheet size remained small, with total assets at €9.6K in 2025, compared with €9.9K in 2024 and €14.3K in 2023. Equity was negative throughout the period and declined to -€25.6K, while liabilities increased to €35.4K. Asset turnover was 1.07x in 2025, and revenue per employee was €10.3K. Ratios linked to equity are distorted by the negative equity position and should be interpreted cautiously.